← GoodRx Holdings, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | $43.8m |
$66.0m
+50.82%
|
($293.6m)
-544.56%
|
$25.3m
+108.60%
|
($32.8m)
-229.99%
|
($8.9m)
+72.99%
|
$16.4m
+284.82%
|
$30.4m
+85.72%
|
— | |
| Depreciation and amortization | $9.8m | $13.6m | $18.4m | $34.5m | $54.2m | $107.7m | $69.5m | $85.2m | $88.6m | |
| Amortization of debt issuance costs and discounts | $1.2m | $3.4m | $3.4m | $3.4m | $3.4m | $3.4m | $2.5m | $1.8m | — | |
| Deferred income taxes | ($2.4m) | ($5.7m) | ($10.9m) | $12.9m | ($497k) | ($65.6m) | ($11.9m) | $20.1m | $29.8m | |
| Stock-based compensation expense | $1.8m | $3.7m | $397.3m | $160.5m | $120.2m | $104.8m | $99.0m | $76.6m | $69.1m | |
| Stock-based compensation included in capitalized software | — | $385k | $2.4m | $7.7m | $9.0m | $13.1m | $16.1m | $15.1m | $69.1m | |
| Accounts receivable | ($12.8m) | ($14.5m) | ($16.1m) | ($43.9m) | $1.4m | ($26.5m) | ($2.3m) | ($88.0m) | $8.7m | |
| Accounts payable | $665k | $515k | $2.2m | $4.2m | ($874k) | $17.5m | ($21.2m) | $4.1m | ($9.3m) | |
| Capitalized software included in accounts payable and accrued expenses and other current liabilities | — | — | $1.3m | $1.1m | $4.2m | $7.8m | $8.1m | $7.7m | — | |
| Accrued expenses and other current liabilities | $77k | $11.2m | $15.0m | $14.0m | ($5.3m) | $21.3m | $25.7m | $1.2m | — | |
| Other | — | — | — | $0 | $0 | $1.3m | $0 | ($2.5m) | — | |
| Prepaid expenses and other assets | ($2.6m) | $102k | ($40.9m) | ($17.1m) | ($13.6m) | ($32.2m) | $6.3m | ($8.4m) | — | |
| Other liabilities | $3.0m | $168k | $2.9m | ($711k) | $2.1m | $914k | ($1.4m) | $2.0m | — | |
| Net cash provided by operating activities | $45.3m |
$83.3m
+84.05%
|
$131.3m
+57.70%
|
$178.8m
+36.12%
|
$146.8m
-17.90%
|
$138.3m
-5.78%
|
$183.9m
+32.97%
|
$167.9m
-8.69%
|
$201.6m
+20.06%
|
|
| Purchase of property and equipment | ($804k) | ($1.4m) | ($20.6m) | ($4.6m) | ($4.0m) | ($1.0m) | ($1.2m) | ($3.5m) | ($69.9m) | |
| Acquisitions | — | ($31.3m) | ($55.8m) | ($140.3m) | ($156.9m) | $0 | $0 | ($43.4m) | ($13.4m) | |
| Net cash used in investing activities | ($3.5m) | ($37.1m) | ($91.6m) | ($178.7m) | ($210.5m) | ($55.8m) | ($70.3m) | ($120.0m) | ($85.8m) | |
| Loss on extinguishment of debt | $2.9m | $4.9m | $0 | $0 | $0 | $0 | $2.1m | $0 | — | |
| Proceeds from long-term debt | $901.8m | $154.6m | $28.0m | $0 | $0 | $0 | $472.0m | $0 | — | |
| Payments on long-term debt | ($294.9m) | ($211.8m) | ($35.0m) | ($7.0m) | ($7.0m) | ($5.3m) | ($639.0m) | ($5.0m) | — | |
| Payments of debt issuance costs | ($25.6m) | ($2.2m) | ($1.3m) | $0 | $0 | $0 | ($2.7m) | $0 | — | |
| Repurchases of Class A common stock | — | — | $0 | $0 | ($101.7m) | ($104.0m) | ($158.8m) | ($216.4m) | — | |
| Employee taxes paid related to net share settlement of equity awards | — | $0 | ($78.7m) | ($57.7m) | ($20.6m) | ($65.5m) | ($29.8m) | ($14.5m) | — | |
| Net cash used in financing activities | ($24.7m) |
($54.8m)
-121.48%
|
$905.8m
+1753.52%
|
($30.5m)
-103.37%
|
($120.2m)
-293.82%
|
($167.4m)
-39.23%
|
($337.5m)
-101.62%
|
($234.5m)
+30.53%
|
($101.0m)
+56.94%
|
|
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Non-cash operating lease expense | $45.3m | $2.1m | $4.5m | $3.1m | $3.3m | $4.1m | $4.2m | $4.0m | $201.6m | |
| Loss on operating lease assets | — | $0 | $961k | $1.4m | $12.6m | $1.4m | $0 | $4.4m | — | |
| Loss on disposal of capitalized software | — | — | — | $0 | $0 | $8.0m | $0 | $0 | — | |
| Loss on minority equity interest investment | — | — | — | $0 | $0 | $4.0m | $0 | $0 | — | |
| Prescription reimbursement assets | — | — | — | — | — | ($15.5m) | ($7.5m) | ($75.4m) | — | |
| Prescription reimbursement liabilities | — | — | — | — | — | $5.4m | $10.4m | $114.3m | — | |
| Operating lease liabilities | — | ($2.3m) | $4.6m | ($2.4m) | ($4.0m) | ($2.9m) | ($5.0m) | ($6.3m) | — | |
| Capitalized software | ($2.7m) | ($4.3m) | ($15.3m) | ($29.9m) | ($51.2m) | ($54.7m) | ($69.1m) | ($70.5m) | — | |
| Proceeds from exercise of stock options | $3.3m | $3.0m | $5.3m | $35.0m | $9.2m | $5.9m | $19.0m | $61k | — | |
| Proceeds from employee stock purchase plan | — | — | — | $0 | $0 | $1.4m | $1.8m | $1.3m | — | |
| Net change in cash and cash equivalents | $17.1m | ($8.6m) | $945.5m | $30.5m | ($183.9m) | ($84.9m) | ($223.9m) | ($186.5m) | — | |
| Cash and cash equivalents | ||||||||||
| Beginning of period | $34.6m | $26.1m | $971.6m | $941.1m | $757.2m | $672.3m | $448.3m | $261.8m | — | |
| Income taxes paid, net of refunds received | — | $0 | ($78.7m) | ($18.1m) | $4.4m | $17.2m | $23.6m | $13.1m | — | |
| Interest paid | $18.7m | $48.4m | $24.5m | $20.2m | $30.7m | $48.8m | $55.1m | $40.8m | $40.8m | |
| Right-of-use assets obtained in exchange for operating lease liabilities | — | $29.5m | $234k | $2.9m | $22.5m | $52k | $2.0m | $9.2m | — | |
| Capitalized software transferred from prepaid assets | — | — | — | $0 | $0 | $5.8m | $0 | $0 | — |